 Connection
Thomas Anchordoquy to Mice, Inbred BALB C
This is a "connection" page, showing publications Thomas Anchordoquy has written about Mice, Inbred BALB C.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.775 |
|
|
|
-
Tilden SG, Ricco MH, Hemann EA, Anchordoquy TJ. Exploiting a type III interferon response to improve chemotherapeutic safety and efficacy. Eur J Pharm Sci. 2025 Jan 01; 204:106974.
Score: 0.188
-
Betker JL, Jones D, Childs CR, Helm KM, Terrell K, Nagel MA, Anchordoquy TJ. Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery. J Control Release. 2018 09 28; 286:85-93.
Score: 0.121
-
Betker JL, Anchordoquy TJ. Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery. Drug Deliv Transl Res. 2017 02; 7(1):162-167.
Score: 0.109
-
Betker JL, Anchordoquy TJ. Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice. J Pharm Sci. 2017 03; 106(3):872-881.
Score: 0.108
-
Kullberg M, Martinson H, Mann K, Anchordoquy TJ. Complement C3 mediated targeting of liposomes to granulocytic myeloid derived suppressor cells. Nanomedicine. 2015 Aug; 11(6):1355-63.
Score: 0.096
-
Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015 Feb 10; 199:145-55.
Score: 0.094
-
Zhang Y, Bradshaw-Pierce EL, Delille A, Gustafson DL, Anchordoquy TJ. In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. J Pharm Sci. 2008 Jan; 97(1):237-50.
Score: 0.058
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|